pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
T-Cell Therapy · news · pharmadog
← back to T-Cell Therapy
News mentioning T-Cell Therapy
23
stories
Jul 1, 26
STAT+: FDA approves Orca Bio’s T cell therapy for blood cancer patients
stat
May 13, 26
FDA Approves Decitabine/Cedazuridine Plus Venetoclax in Newly Diagnosed AML
onclive
May 13, 26
FDA Approves Sonrotoclax for Relapsed/Refractory Mantle Cell Lymphoma
onclive
May 13, 26
Tirabrutinib and CAR T-Cell Therapy Represent Potential Paradigm Shifts in R/R PCNSL
onclive
May 13, 26
Consensus Recommendations Address Key Controversies in Lymphoma Management
onclive
May 13, 26
BRUIN CLL-321 Trial Impact and Treatment Selection
onclive
May 13, 26
Biomarker-Driven Treatment Decisions and Managing Progression After Frontline Immunotherapy
onclive
May 12, 26
Dr Postow on an Ideal Post-ICI Monitoring Framework in Melanoma
onclive
May 12, 26
Dr Postow on the Timing of Delayed or Re-Emergent irAEs in Melanoma
onclive
May 12, 26
Temple Health’s Fox Chase Cancer Center and Labcorp Collaborate to Test Ultra-Sensitive Blood-Based Assay for Early-Stage Lung Cancer Recurrence Risk
onclive
May 12, 26
GU Cancer Experts Highlight Top Abstracts to Watch During ASCO 2026
onclive
May 12, 26
Unmet Needs in Endometrial Cancer
onclive
May 12, 26
EGFR-Mutated NSCLC: Mechanism and Clinical Role of TROP2-Directed ADCs
onclive
May 12, 26
Future Directions in Relapsed and Refractory Multiple Myeloma
onclive
May 12, 26
Dr Parikh on the Feasibility and Importance of Immunotherapy Trials in Anal Cancer
onclive
May 12, 26
Sequencing Strategies After Progression in Multiple Myeloma
onclive
May 12, 26
EGFR-Mutated NSCLC: Targeting MET-Driven Resistance in Second-Line Therapy
onclive
May 12, 26
Sequencing ADCs in Endometrial Cancer
onclive
May 12, 26
Second Clinical Scenario - Progressive Disease Despite Hematocrit Control
onclive
May 11, 26
MimiVax and Roswell Park Open Phase 2 Trial of SurVaxM for Patients with Metastatic Neuroendocrine Tumors
onclive
May 11, 26
FDA Approval of Brexu-Cel for R/R MCL Calls for Raised Awareness of CAR T-Cell Therapy Safety Considerations
onclive
May 8, 26
Dr Gruenbaum on Where Alternative Options to BTK Inhibitors Stand in MCL
onclive
May 7, 26
Track the Lung Cancer Abstracts That are Gaining Attention at ASCO 2026
onclive
